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1. Introduction 
Venous occlusive disease encompasses a variety of clinical entities that range the spectrum 
from being catastrophic and life threatening, such as massive pulmonary embolism, to 
disease states that may have an occult presentation, such as inferior vena cava occlusion. 
Other examples of veno-occlusive disease states include deep venous thrombosis and right 
atrial masses. When venous occlusion is characterized by an overwhelming volume of 
offending material, clinical therapy may be a significant challenge. This chapter examines 
the historical background of therapy directed at venous occlusion, and outlines a simplified 
technique for addressing the occurrence of major undesirable intravascular material. 
2. Etiology and incidence 
The majority of undesirable material presenting in the major venous circulation have their 
origins in the lower extremity veins. Deep venous thrombosis has an estimated annual 
incidence of over 2 million cases in the United States (Hirsh & Hoak, 1996), and accounts for 
approximately 600,000 hospitalizations per year (Schreiber, 2010). The genesis of venous 
thrombosis continues to be aptly characterized by the observations of Virchow in 1856 
(Virchow, 1998, as cited in Lopez et al., 2004), who is credited with associating the triad of 
(1) venous stasis, (2) endothelial injury and (3) hypercoagulability with the formation of 
intravascular clot. The incidence of pulmonary embolism is closely tied to the occurrence of 
deep venous thrombosis, so much so that the complex of deep venous thrombosis and 
pulmonary embolism is defined by the term “venous thromboembolism”. It is estimated 
that approximately 50% of patients with deep venous thrombosis have detectable 
pulmonary emboli (Hirsh, 1996). Lower extremity deep venous thrombosis in the distal 
vessels, e.g. calf vein thrombosis, has commonly been held to be relatively benign, and 
mostly asymptomatic; however, some studies have shown that propagation of calf vein clot 
above the popliteal level occurs in approximately 15% of patients (Lohr et al., 1991). Upon 
propagation to the popliteal vein, the risk of measurable pulmonary embolism increases to 
approximately 40% (Kakkar et al., 1969, as cited in Hirsch & Hoak, 1996). 
Risk factors for venous thromboembolism are associated with conditions that alter elements 
of Virchow’s triad. These include increasing age, surgery, trauma, hospital or nursing home 
www.intechopen.com
 Special Topics in Cardiac Surgery 
 
128 
confinement, malignancy, paralytic neurologic disease, presence of an indwelling venous 
catheter or pacing lead, varicose veins, previous superficial vein thrombosis, pregnancy, and 
oral contraceptive use (Heit, 2002). The recurrence rate for patients with a single episode of 
venous thromboembolism is approximately thirty percent over ten years. 
The incidence of pulmonary embolism in the U.S. is estimated to be 1.35 million cases per 
year (Banovac et al., 2010). Predicted outcomes for patients with pulmonary embolism 
vary greatly with the hemodynamic stability of the patient upon presentation. Patients 
with a systolic arterial blood pressure below 90 mm Hg are deemed to have massive 
pulmonary embolism, while patients with a systolic pressure equal to or above 90 mm Hg 
are categorized as having non-massive pulmonary embolism. In the International 
Cooperative Pulmonary Embolism Registry involving 2,342 patients, the vast majority 
(95.5%) had non-massive pulmonary embolism, while 4.5% had massive pulmonary 
embolism. Patients with massive pulmonary embolism had a 90 day mortality of 52.4%, 
compared with a 90 day mortality of 14.7% in patients with non-massive pulmonary 
embolism (Kucher et al., 2006). In hospital mortality for patients with pulmonary 
embolism rose from 8.1% in clinically stable patients to 25% in unstable patients, and 
increased to 65% in patients requiring cardiopulmonary resuscitation, in a separate study 
of 1,001 patients (Kasper et al., 1997). 
Inferior vena cava thrombosis is also associated with deep venous thrombosis, although to a 
lesser extent than the tie between deep venous thrombosis and pulmonary embolism. The 
frequency of IVC thrombosis in patients with deep venous thrombosis is estimated to be 
between 4 - 15% (Fernandez & Geehan, 2008). Other causes of inferior vena cava thrombosis 
include malignancy, trauma, surgery, abdominal aortic aneurysm, and indwelling venous 
catheters. In one series, carcinoma of the kidney was the most common cause of IVC 
thrombosis, accounting for 31% of cases presenting over a 23 year period (Siqueira-Filho et 
al., 1976). The actual incidence of inferior vena cava thrombosis is difficult to cite, due to the 
variability of its presentation. It is estimated that in patients with IVC thrombosis, over one-
half remain asymptomatic until their initial presentation with pulmonary embolism. 
Iatrogenic causes of inferior vena cava thrombosis are also significant. IVC thrombosis 
maybe a complication of vena cava filter placement, in the treatment of or prophylaxis for 
pulmonary embolism. The occurrence of IVC thrombosis was 2.7% in a 26 year review of 
1731 patients implanted with 1765 vena cava filters (Athanasoulis et al., 2000). Vena cava 
thrombosis may also be caused by indwelling intravascular devices such as pacemaker 
leads, parenteral nutrition catheters, or hemodialysis catheters (Krug & Zerbe, 1980; 
Mulvihill & Fonkalsrud, 1984; Gouge et al., 1988). 
Masses presenting in the cardiac portion of the venous circulation are relatively rare. Most 
of such masses are primary atrial myxomas. A study of 33108 consecutive cardiac surgical 
patients found an incidence of right atrial myxoma to be 0.036%; this incidence represents 
less than 10% of all atrial myxomas, as most atrial myxomas are left sided. Thrombus 
formation on the tumor surface or dislodged tumor fragments may cause pulmonary 
embolism. Thrombus originating in the iliofemoral system or the inferior vena cava may 
propagate into the right atrium (Khurana & Tak, 2004). Once clot presents in the right 
atrium, the prognosis is poor without active thrombectomy. A review of the literature 
involving twenty patients with right atrial thrombus found that the condition was 
uniformly fatal without treatment, while a 50% mortality rate was observed when either 
anticoagulation or thrombolytic therapy was administered. When surgical extraction was 
performed, the mortality rate was reduced to 14% (Armstrong et al., 1985). 
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3. Therapeutic history 
3.1 Medical therapy 
Medical treatment of venous thromboembolism was instituted in 1960 with the first 
randomized clinical trial evaluating the efficacy of anticoagulation in patients with 
pulmonary embolism (Barrett & Jordan, 1960). Anticoagulation therapy does not resolve 
existent thrombus, but prevents its propagation, and significantly reduces the mortality rate 
of pulmonary embolism. Untreated pulmonary embolism carries a mortality rate of 
approximately 30%; this is reduced to approximately 8% when anticoagulation is instituted 
(Banovac et al., 2010). The typical therapeutic approach involves intravenous infusion of 
unfractionated or low molecular weight heparin, followed by oral anticoagulation with 
warfarin , which is continued for a period of several months. It has been suggested that little 
benefit is gained by extending anticoagulation therapy from three to six months in venous 
thromboembolism patients (Campbell et al., 2007). 
Fibrinolytic agents provide active dissolution of clot; they were introduced into clinical 
treatment of venous thromboembolic disease in the 1970s (Tibbutt et al., 1974). 
Streptokinase, urokinase, and recombinant tissue plasminogen activator (rTPA) are 
compounds available for fibrinolytic therapy. All three agents convert plasminogen to 
plasmin, with subsequent enzymatic degradation of fibrin clot. Studies on the efficacy of the 
three available fibrinolytic agents demonstrate no difference in clot resolution after twenty-
four hours (Almoosa, 2002). The positive effect of thrombolytic agents is partially offset by 
their potential for major bleeding complications, including intracerebral hemorrhage. The 
risk of hemorrhage during fibrinolytic therapy varies between 6 – 20% (Harris & Meek, 
2005). A meta-analysis of nine randomized, controlled clinical trials comparing 
anticoagulation alone to anticoagulation plus thrombolysis demonstrated no difference in 
overall mortality between the two treatment regimes in non-selected patients with acute 
pulmonary embolism (Thabut, G. et al., 2002). Therefore, fibrinolytic therapy is indicated for 
patients with massive pulmonary embolism characterized by hypotension, or potentially for 
normotensive pulmonary embolism patients demonstrating right heart dysfunction, as this 
subgroup of patients has been associated with a higher risk of mortality in previous studies 
(Goldhaber, 1993, as cited in Harris & Meeks, 2005). Fibrinolytic agents may be delivered 
intravenously, or selectively into the pulmonary artery at the site of occlusion. A 
prospective, multi-center trial comparing intrapulmonary fibrinolytic infusion with 
intravenous fibrinolytic administration found no significant benefit with intrapulmonary 
catheter therapy (Verstraete et al., 1988). Instead, a prolonged intravenous thrombolytic 
infusion over seven hours appeared to yield a superior benefit to a single infusion over two 
hours. Direct insertion of an infusion catheter into the substrate of the embolus has been 
suggested as a more efficacious method of fibrinolytic delivery. Insufficient clinical data is 
available at this time to establish superiority of intra-embolic infusion over intrapulmonary 
or intravenous fibrinolysis. 
3.2 Surgical therapy 
Patients with massive venous thromboembolism and particularly those with 
contraindications to thrombolytic therapy are candidates for surgical thrombectomy and 
embolectomy. Pulmonary embolectomy is a substantial procedure, necessitating a median 
sternotomy and cardiopulmonary bypass, but without cardioplegic arrest. An arteriotomy 
in the main pulmonary artery is performed to allow instrumental extraction of thrombus 
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under direct vision, in an en bloc fashion, if possible. In one surgical series of 29 consecutive 
patients, surgical pulmonary embolectomy was successful in all cases, and the resultant 
survival rate at one month was 89% (Aklog et al., 2002). A review of 1,300 total patients 
undergoing operative pulmonary embolectomy in 46 reported series from 1961 to 2005 
demonstrated an average mortalityof 30% (Stein et al., 2007). Due to its degree of 
invasiveness, surgical embolectomy is generally reserved as the last therapeutic option. 
3.3 Catheter therapy 
Instrumentation for surgical embolectomy dates back to 1963, with the introduction of the 
Fogarty embolectomy balloon catheter (Fogarty, 1963). The venous thrombectomy version of 
the Fogarty balloon is a 6F or 8F catheter with inflated balloon sizes up to 19 mm in 
diameter. The venous thrombectomy catheter is primarily applied to patients with deep 
venous thrombosis. It incorporates a flexible distal tip to facilitate catheter passage through 
venous valves. Procedures are performed in the operating theater, with surgical access used 
to gain vascular control during the thrombectomy process. 
A variety of devices have been devised for a percutaneous approach to thrombectomy. 
Greenfield developed a suction tip catheter for pulmonary embolectomy in 1971 (Greenfield 
et al., 1971). The catheter was previously available in the form of a 10F steerable catheter 
with either a 5 mm or a 7 mm diameter cupped tip. Percutaneous entry was performed in 
either the femoral or jugular vein, and embolectomy conducted under fluoroscopic control. 
Vacuum was established by means of a syringe to aspirate a portion of the embolus into the 
cup, whereupon sustained vacuum was maintained as the catheter was withdrawn to 
remove the clot. Multiple passes of the suction cup catheter were applied until 
improvements in the pulmonary artery pressure and cardiac output denoted a successful 
clinical result. A series of 46 patients undergoing Greenfield suction pulmonary 
embolectomy between 1970 to 1992 demonstrated an overall success rate of 76%, with a one 
month survival rate of 70% (Greenfield et al., 1993). Conventional straight catheter sheaths 
may be employed for percutaneous embolectomy. An approach termed the “Meyerovitz 
technique” applies vacuum via a connected 60 cc syringe to a readily available 8F or 9F 
coronary guiding catheter without distal side holes, advanced through a 10F introducer 
sheath (Goldhaber, 1998). However, limited volumes of clot are extracted, due to the small 
caliber of the guiding catheters used. 
Multiple catheter designs address venous thromboembolism via clot fragmentation. 
Peripheral angioplasty balloon catheters have been applied to restore patency in 
intraluminal occlusion. Dilatation of thrombus in large caliber vessels may result in 
significant distal embolization; therefore, balloon angioplasty may be combined with 
wallstent placement to decrease recurrent embolism resulting from dislodgement of balloon 
dilated endoluminal thrombus. Another approach to fragmentation therapy utilizes manual 
rotation of a pigtail catheter to disrupt clot, with concomitant site specific thrombolytic 
injection to augment the mechanical therapy (Schmitz-Rode et al., 1998). The 5F pigtail 
catheter is ensheathed in a coaxial 5.5F introducer sheath. This device seeks to recanalize an 
occluded vessel, without retrieval of disrupted segments. Treated patients are subjected to 
distal embolization that may potentially be clinically significant. Another specialized 
catheter fragmentation device devised by Amplatz applies high speed rotation of a distal 
impeller on a 7F catheter to draw clot towards the impeller, resulting in disintegration of 
thrombus into tiny particles. Micro thrombi generated by this system are not removed from 
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the circulation. The smaller clot fragments generated by the Amplatz impeller is an 
improvement over pigtail embolectomy; however, the presence of circulating micro-
hemolytic fragments may be of concern, particularly if a substantial volume of debris is 
generated. Clot fragmentation coupled with embolic removal has a theoretic edge over 
fragmentation alone. An 11F Aspirex device integrating high-speed rotation of a distally 
situated spiral with vacuum capability is undergoing clinical trials to evaluate its 
effectiveness in pulmonary arteries between 6 mm and 14 mm in diameter (Kuchar, 2007). 
This device combination of mechanical thrombolysis with vacuum removal addresses 
organized thrombus and seeks the removal of fragmentation byproducts. 
Another approach to clot fragmentation is catheter rheolysis. This class of therapeutic 
catheter utilizes a multi-lumen catheter with separate injection and retrieval ports. High 
pressure fluid infusion through one or more injection ports serve to fragment thrombus 
upon contact. Infusion through the injection port or ports create a Venturi effect, 
establishing a pressure differential between the injection and retrieval ports that create a 
backflow through the retrieval lumen for removal of thrombus fragments and infused fluid. 
Rheolytic catheters are sized in the 6F to 7F range, and are not designed to be used in vessels 
greater than 12 mm in diameter (Kuchar, 2007). Their application in massive pulmonary 
embolism has been described in small clinical series, with resultant limited effectiveness 
(Siablis, 2005, Chiam, 2005, Zeni, 2003, and Koning, 1997, as cited in Kuchar, 2007). 
3.4 En Bloc removal of undesirable intravascular material 
A simplified approach to the en bloc removal of undesirable intravascular material is 
proposed. One of the authors noticed that during surgical embolectomy, it is often possible 
to perform en bloc removal of a large mass of organized thrombus, when a venous drainage 
cannula inserted into the main pulmonary artery gains purchase of the tail of the clot. The 
flow rate established by the cardiopulmonary bypass pump generates significant vacuum 
that in some cases may pull a thrombotic cast of the pulmonary vasculature into the 
extracorporeal circulation, where it is trapped by the in-line filter. In other cases, the large 
caliber of the main pulmonary artery and the subsequent girth of the embolus prevent its 
introduction into the venous outflow cannula; however, it may be grasped by the cannula 
tip and extracted via the pulmonary arteriotomy. The mechanics of thrombectomy gained as 
a result of the open surgical experience suggested a possible technique of percutaneous 
venous extraction. An extracorporeal circuit may be established containing a large bore 
outflow line, a centrifugal pump, an in-line filter, and an inflow line. The distal end of the 
venous outflow cannula is fitted with a balloon-activated funnel tip that expands to the 
luminal diameter of the occluded vessel. The venous outflow cannula is advanced into 
proximity of the obstructing venous material, while the venous inflow cannula is inserted 
into a separate venous entry site. Activation of the centrifugal pump creates a uni-
directional flow that serves two functions: One, it creates a vacuum at the funnel drainage 
side to extract undesirable intravascular material; and two it performs simultaneous 
reinfusion of filtered blood volume to maintain circulatory homeostasis. The extracorporeal 
circuit is placed percutaneously or via femoral venous cutdown. The technique establishes a 
venous to venous bypass circulation without oxygenation, powered by a compact 
centrifugal pump generating a flow rate up to 5 liters per minute. The sizes of both outflow 
and inflow venous cannulae are maximized, to accommodate the large girth of the 
pulmonary vasculature. Whereas previous suction thrombectomy devices extracted clot in 
piecemeal fashion with multiple catheter insertions and removals, due to their limited bore, 
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the extracorporeal veno-venous system strives for en bloc extraction, with intraluminal 
passage of clot in the venous cannulae. 
3.4.1 Instrumentation and technique 
Elements of the funnel drainage cannula and extracorporeal circuit used to extract occluding 
venous material are shown in Figure 1. The funnel cannula (AngioVac® Cannula, Vortex 
Medical Inc., Norwell, MA) contains a 22F body with distal fingers that are balloon 
expandable to generate a maximal funnel diameter of 48F. The funnel drainage cannula is 
connected to ½ inch polyvinyl chloride tubing that leads to the in-line filter with a 90 cc 
capacity. The centrifugal pump is downstream of the filter, and connected to the reinfusion 
cannula, completing the extracorporeal circuit. In preparation for establishment of 
extracorporeal bypass, a 10,000 unit bolus of intravenous heparin is administered to the 
patient, and a constant intravenous infusion of approximately 1,000 units per hour 
continued to maintain the patient’s activated clotting time (ACT) at 300 seconds. If the ACT 
is maintained at 300 or above, use of a heparin coated bypass circuit is unnecessary. Prior to 
use, the circuit is primed with normal saline, yielding a closed system that accomplishes 
vacuum extraction, filtering and reinfusion in concurrent fashion. With use of the Rotaflow 
centrifugal pump (MAQUET Cardiovascular, Wayne, New Jersey), priming of the circuit 
requires approximately 500 cc of saline. In use, venous access is established via the femoral 
or jugular vein, and an angiographic catheter advanced to the site of the occlusion. If 
extraction of pulmonary emboli in a branch vessel is anticipated, cannulation of the target 
vessel is performed using a 5F to 8F pigtail catheter (Andrews, 2004), and an 0.038” 
guidewire left in position. A 26F introducer sheath (Gore® DrySeal Sheath, W.L. Gore & 
Associates, Inc., Medical Products Division, Flagstaff, AZ) is inserted in the femoral or 
jugular venous access site and the drainage cannula fitted with its internal tapered dilator is 
advanced over the emplaced 0.038” guidewire to position the funnel tip approximately 10 
cm proximal to the occlusion. The dilator is removed from the drainage cannula, and the 
balloon inflated with saline to a pressure of 1 atmosphere to expand the collecting funnel. 
The centrifugal pump is activated prior to advancement of the funnel cannula towards the 
occlusion. The rotational speed of the pump is increased in increments of 500 ml/minute 
until thrombus extraction occurs. Flow rate indicated on the pump generally increases as the 
speed is increased. A sudden drop to zero flow may be a signal that a large mass has 
become seated in the funnel. Pump velocity is maintained, and as the mass is compressed 
and extracted through the cannula, flow will be re-established. If the diameter and density 
of a mass of dislodged organized thrombus prevents its passage through the venous 
drainage cannula, the cannula may be removed from the body and its lumen cleared 
externally. Following suction embolectomy, a completion venogram or pulmonary 
arteriogram is performed via the drainage cannula to evaluate the completeness of 
thrombus extraction. 
3.4.2 Functional mechanics of En Bloc intravascular extraction 
Intravascular extraction with the funnel cannula is a flow directed process, with the 
centrifugal pump generating sufficient flow to perform suction embolectomy at one end of 
the circuit and vascular reinfusion at the opposite end of the circuit. The balloon situated at 
the funnel portion of the drainage cannula not only serves to expand the funnel for vessel 
wall apposition and removal of intravascular material, but also provides inflow regulation 
during the extraction procedure (Figure 2). Modulation of antegrade venous flow assists the 
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Fig. 1. Elements of the funnel drainage cannula and extracorporeal circuit 
centrifugal pump in generating the necessary retrograde flow to initiate movement of the 
thrombotic material and its subsequent excursion the length of the drainage cannula. The 
degree of collateralization in the native circulation facilitates intravascular extraction, as it 
preserves the potential for retrograde flow at the treatment site. If retrograde flow at the 
occlusion site is diminished or removed, intravascular extraction may be inhibited. In order 
to delineate the significance of retrograde flow on the dynamics of en bloc extraction, a flow 
model was constructed to allow empirical evaluation of the vacuum extraction process. 
3.4.3 Material and methods 
Branched, tapering vinyl tubing was connected with fittings in a configuration that mimics 
the morphology of the pulmonary vasculature, and a valve was placed immediately distal to 
the site of embolic extraction (Figure 3). Saline was heated to 37 degrees Celsius and 
continuously circulated through the circuit by means of an impeller pump and a peristaltic 
pump in series, at a flow rate of 5.0 L/minute. Organized thrombus was modeled using calf 
liver sectioned into15 mm x 80 mm strips. Calf liver was used to model thrombus, as its 
density is similar to the density of mammalian clot (Nahimyak, 2006 amd Baraislas. 2007), 
and it lacks the propensity for disintegration in a mechanical flow model. With the 
thrombus model placed in the vascular circuit in a position equivalent to the main 
pulmonary artery, the valve proximal to the thrombus model was adjusted to three different 
positions: (1) completely closed position, (2) completely open position, and (3) partially 
closed position. The separation distance at thrombus model capture, centrifugal pump 
speed at capture, and flow rate generated in the funnel drainage cannula at capture were 
measured. 
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Fig. 3. Test fixture to evaluate the mechanics of the vacuum extraction process 
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At a separation distance of 11 cm between the tip of the funnel and the clot model, no 
movement of the clot was noted with the valve closed completely, at all pump flow rates 
increased to a maximum of 6 liters per minute. Advancement of the funnel cannula to the 
proximity of the clot model, at 5 cm of separation, allowed extraction at 4.6 liters per minute 
of pump flow rate. With the valve completely open, allowing ample backflow, the clot 
model was extracted at a separation distance of 11 cm with a pump flow rate of 2.5 liters per 
minute. When the valve was 80% closed, clot extraction did not occur at 11 cm; however, 
removal was observed at 5 cm of separation distance at a pump flow rate of 6 liters per 
minute. 
3.4.5 Clinical experience 
Between December 2009 and May 2011, a total of 49 patients underwent removal of 
undesirable intravascular material using the funnel-tipped venous drainage cannula under 
extracorporeal veno-venous bypass. Procedures were conducted both in the fluoroscopy 
suite, and in the surgical theater under C-arm guidance. Veno-occlusive states addressed by 
these procedures included the following: (1) A retained segment of fibrin sheath from a 
pacemaker lead was extracted from the right atrium of a patient. (2) Vegetation was 
removed from the tricuspid valve of a patient who developed endocarditis from an 
indwelling line. (3) Thrombus and tumor was removed from a patient with an inferior vena 
cava occlusion due to a retroperitoneal malignancy. (4) A saddle embolus was removed 
from a patient with pulmonary embolism. (5) Organized and soft thrombus was removed 
from a patient presenting with bilateral iliofemoral and inferior vena cava occlusion. IVC 
thrombosis and pulmonary embolism accounted for the majority of the procedures, 43% and 
29%, respectively. Seven patients had right atrial thrombus removed via suction 
embolectomy; in four of these patients, the thrombus extended up into the superior vena 
cava, and cannulation of the the SVC was required to remove the occluding clot. Four 
patients had vegetative endocarditic masses removed from their right atria. Several 
representative procedures may be detailed as follows: 
Example 1: 
A 63 year old female presented with severe bilateral lower extremity edema, bordering on 
phlegmasia cerulean dolens. She had an inferior vena cava filter placed two weeks 
previously for deep venous thrombosis, and her history is also significant for a recent 
neurosurgical procedure. The patient’s situation was additionally complicated by a 
documented history of heparin induced thrombocytopenia. A venogram demonstrated 
complete IVC thrombosis extending proximal to the IVC filter and involving both 
iliofemoral systems distally (Figure 4). 
Thrombolytic therapy was contraindicated in this patient, due to the recent neurosurgical 
procedure and the history of heparin induced cytopenia. Rheolytic thrombectomy, applied 
in an attempt to recanalize the vena cava and distal venous circulation, was unsuccessful. 
The patient was brought back to the fluoroscopy suite, where the suction funnel cannula 
was inserted through a 26F introducer sheath via a percutaneous right femoral vein entry 
site. Upon establishment of flow via the centrifugal pump, a large amount of fresh and 
organized thrombus was retrieved in the filter. The suction cannula was advanced into the 
vena cava, as well as the contralateral iliac vein. Two full filter canisters of occluding 
material, totaling 180 cc in volume, was removed from the patient (Figure 5). In addition, the  
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Fig. 4. Venogram depicting complete IVC thrombosis 
previously placed IVC filter was removed through the central lumen of the suction cannula, 
while the extracorporeal circulation was maintained to prevent distal embolization from 
occurring during vena caval filter retrieval. Upon completion of the embolectomy 
procedure, a new IVC filter was placed. The post-extraction venogram showed a widely 
patent IVC and iliofemoral vasculature (Figure 6). The patient remained stable throughout 
the procedure. The procedure was conducted under administration of intravenous 
Bivalirudin (Angiomax®, The Medicines Company, Parsippany, NJ), due to the patient 
history of heparin induced thrombocytopenia. 
Example 2: 
A 40kg 23 year old female on renal dialysis via an indwelling right subclavian catheter, with 
a history of end stage renal disease and a failed renal transplant, presented with chest pain. 
She was found to have an embolus in a distal lobar branch of the left pulmonary artery, and 
an echocardiogram and CT scan revealed a fluttering clot at the distal tip of the subclavian 
catheter, and a 3 cm sessile mass on the free wall of the right atrium (Figure 7). Suction 
embolectomy was performed under general anesthesia in the operating room under 
echocardiographic guidance. Due to the small stature of the patient and subsequent limited 
caliber of her vasculature, the left and right femoral veins were exposed via open groin 
incisions. The 22F funnel cannula was introduced directly into the right femoral venotomy, 
and a 17F cannula placed into the left femoral vein for reinfusion. The funnel cannula was 
advanced into the right atrium and positioned in proximity to the subclavian catheter. Flow 
was initiated with the centrifugal pump, and chronic thrombotic material trapped by the 
filter. The subclavian dialysis catheter was removed, and the cannula advanced into the 
superior vena cava while circulating flow was maintained. A large amount of organized 
thrombus was noted in the filter (Figure 8). The echocardiogram showed removal of all 
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Fig. 5. Thrombotic material captured in two filters 
 
 
Fig. 6. Completion venogram demonstrating recanalization of the IVC and iliac veins 
mobile thrombus, and a patent proximal superior vena cava (Figure 9). The sessile mass 
remained attached to the wall of the right atrium; no additional attempts were made to 
detach this immobile mass. A new dialysis catheter was placed, and the patient was 
discharged from the hospital under anticoagulation. 
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Fig. 7. Echocardiogram depicting mobile thrombus and sessile mass in the right atrium 
 
 
Fig. 8. Organized thrombus extracted from right atrium and superior vena cava 
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Fig. 9. Post extraction echocardiogram depicting absence of mobile thrombus  
3.4.6 Clinical results 
Of the 49 total patients in this series, 27 patients were male, and 22 female. The average age 
of the male patients was 53 years with a range between 27 and 88 years, and the average age 
of the female patients was 51 years, with a range between 19 and 82 years. Twelve of the 
procedures were performed in a totally percutaneous manner, while thirty-seven 
procedures were performed via surgical exposure of the femoral veins. Success of an 
extraction procedure is defined as removal of occluding material, fluoroscopic or 
echocardiographic evidence of venous patency, and stabilization of patient hemodynamic 
parameters. Forty of the forty-nine procedures resulted in removal of intravascular material 
for an 80% overall success rate. In 9 cases, minimal or no material was removed. In one case, 
spontaneous fragmentation and distal embolization of the thrombus occurred prior to 
initiation of the suction embolectomy procedure. One perioperative death occurred in a 
hemodialysis patient with a right atrial mass and an inferior vena cava occlusion. 
Hemothorax from a suspected guidewire perforation of the right atrium was noted during 
the procedure. The patient was brought to the operating room, and surgical exploration 
found a substantial fibrotic mass encasing the right atrium and inferior vena cava, 
preventing cannulation for cardiopulmonary bypass. The patient survived the surgery, but 
succumbed within 48 hours in the intensive care unit. No hemolysis or thrombocytopenia 
was observed in any of the patients in this study, and the patients’ hematocrit values 
remained stable post procedure.  
www.intechopen.com




The propensity for clot to propagate as well as to organize renders treatment of 
thromboembolic disease difficult. Anticoagulation addresses further propagation of 
thrombus; however, once a patient presents with a significant mass of clot, vascular 
recanalization becomes a formidable task. Complete occlusions in major or great venous 
vessels tend to be unresponsive to thrombolytic therapy, as circulating thrombolytic agents 
are unable to access the inner mass of a substantial body of clot that typifies massive 
pulmonary embolism or total vena cava occlusion. Thrombolytic dissolution occurs at the 
periphery of the occlusion, proceeding progressively inwards with time. Hemodynamic 
instability may curtail the opportunity window for therapeutic intervention, and immediate 
bulk extraction of occlusive material is warranted. Percutaneous interventional devices 
utilizing mechanical or rheolytic fragmentation of clot increase the rate of thrombolysis. 
Dissolution is a function of the amount of interaction achieved by the device with the clot. 
Higher surface contact area between the active components of the device and resident clot 
yields greater thrombolytic activity. Presently available percutaneous devices are limited by 
their size relative to clot in the great vessels. The luminal cross-sectional area of a 7F catheter 
is equal to 3 mm2, which encompasses 0.5% of the surface area of a 30 mm diameter inferior 
vena cava or pulmonary artery with a luminal cross-sectional area of 615 mm2. This means 
that a 7F catheter approaching an occluding thrombus in the vena cava contacts only 0.5% of 
the cross-sectional area of a clot on a single pass. An impractical number of catheter passes 
would be required to clear a total occlusion in the great vessels. 
The large bore of the funnel cannula facilitates material removal from the great vessels. The 
large conduit size also minimizes the potential for hemolysis during vacuum extraction. 
Suction therapy is conducted by a centrifugal pump which generates typical flow rates up to 
5 liters per minute via the 22 F cannula. At this flow rate and cannula size, laminar flow is 
maintained in the extracorporeal circuit, providing atraumatic passage for circulating 
erythrocytes. 
4. Conclusion 
Removal of undesirable intravascular material using extracorporeal recirculation with a 
funnel venous drainage cannula seeks to mimic surgical removal of massive emboli, by 
maximizing physical contact with the leading edge of the occlusion, and conducting en bloc 
removal of substantial embolic masses. The significant flow rates (on the order of 4 or 5 liters 
per minute) established in the drainage cannula while extracting major emboli, are matched 
by simultaneous reinfusion to maintain hemodynamic stability during the embolectomy 
process. A funnel cannula tip that matches the size of the occluded vessel and a high 
circulating flow rate are necessary elements to facilitate embolectomy. Bench top tests 
indicate that backflow must be present to support the level of pump flow rate that generates 
vacuum sufficient to remove large masses. In some of the procedures that yielded little or no 
material extraction, it is possible that a lack of backflow was exhibited due to absent or 
severely limited retrograde collateralization. Guidewire or angiographic catheter passage 
through the thrombotic substrate may yield partial recanalization that provides the requisite 
degree of retrograde flow for successful embolic removal. Another cause of unsuccessful 
extraction may be an advanced degree of fibrotic attachment associated with aged thrombus 
that is not amenable to vacuum dislodgment. Further clinical experience will delineate 
additional associated techniques and define best patient selection criteria for optimal 
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application of vacuum extraction with the funnel cannula. The experience to date generates 
a sense of optimism that suction embolectomy with associated extracorporeal recirculation 
has potential as a functional therapeutic component in the battle against thromboembolic 
disease. Continued research into this and other approaches is certainly warranted. 
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